César leads the Bioanalytical Applications Team at the Integrated Photonics and Applications Centre (InPAC) at RMIT University, Australia. As a nano-biotechnologist, he specializes in lab-on-a-chip technologies that integrate photonics and microfluidics. His team develops biomedical lab-on-a-chip devices capable of analyzing biomarkers—from DNA and RNA to proteins and cells—to reflect the body’s internal state. Their work primarily focuses on immunology, cardiovascular diseases, and cancer. He is dedicated to advancing photonic biosensor detection through sophisticated signal processing techniques and pushing the limits of biomedical analysis with innovative microfluidic devices. His team integrates these technologies into compact, versatile lab-on-a-chip devices.

He is also a committed supervisor and mentor, fostering a community of researchers in the lab-on-a-chip and MedTech fields. Collaborating with engineers, biomedical groups, clinicians, and industry, César aims to develop diagnostic and biomedical devices that are user-friendly, instantaneous, and portable. In 2021, he co-founded HatiSens Pty Ltd, a medical technology startup focused on improving the efficiency of heart attack diagnostics. To date, his team has secured over AUD $1 million in competitive funding and more than AUD $500k in private industry-led funding.